Logistic regression for HSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Logistic regression for overall population. حسب Krystal Hunter (6820052)

الموضوعات:

BMISES_Data_Part1. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of HSES/LSES population. حسب Krystal Hunter (6820052)

الموضوعات:

Baseline characteristics of overall population. حسب Krystal Hunter (6820052)

الموضوعات:

Diagram of study population. حسب Krystal Hunter (6820052)

الموضوعات:

Scatter plots of the linear regression for the relationship between the duration of the vegetative phase and the average mass of single inflorescences. حسب Torsten Schober (20485754)

Fig 5 - حسب Torsten Schober (20485754)

Fig 4 - حسب Torsten Schober (20485754)

Fig 6 - حسب Torsten Schober (20485754)

Fig 9 - حسب Torsten Schober (20485754)

Patient characteristics. حسب Stefan Halbherr (21353882)

"…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …"

Fig 8 - حسب Torsten Schober (20485754)

Utilization of anticoagulants at eight hospitals from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Inpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Indications for warfarin prescription in outpatients and inpatients in 2023. حسب Wei Luo (80175)

الموضوعات:

Outpatient utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

DDC for four anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

Utilization of anticoagulants from 2019 to 2023. حسب Wei Luo (80175)

الموضوعات:

The expenditure on anticoagulants in the period of 2019-2023(million CNY). حسب Wei Luo (80175)

الموضوعات: